Treatment of necrobiosis lipoidica with low-dose acetylsalicylic acid. A randomized double-blind trial
Beck HI, Bjerring P, Rasmussen I, Zachariae H, Stenbjerg S.
DOI: 10.2340/0001555565230234
Abstract
16 patients with clinically and histologically verified necrobiosis lipoidica lesions were treated with either 40 mg acetylsalicylic acid or placebo daily for 24 weeks in a double-blind controlled study. The lesions became statistically significantly larger in both groups in spite of inhibition of the aggregation of the platelets in the acetylsalicylic group.
Significance
Supplementary content
Comments
